UDIBI

Fecha de publicación: 6 de septiembre de 2022 In Vitro and In Vivo Characterization of a Broadly Neutralizing Anti-SARS-CoV-2...

Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....

Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care. VER MÁS

Fecha de publicación: Marzo 2021 Poor survival in COVID-19 associated with Lymphopenia and Higher Neutrophile-Lymphocyte ratio Ver más

Fecha de publicación: Septiembre 2019 A differential sex-specific pattern of IgG2 and IgG4 subclasses of anti-drug antibodies (ADAs) induced...

Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes. VER MÁS

Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. VER MÁS

Regulatory Pathway for Licensing Biotherapeutics in Mexico. VER MÁS